20/20 takes orders for 1st POC fingerstick COVID-19 test

By LabPulse.com staff writers

October 7, 2020 -- 20/20 BioResponse is now accepting orders for its point-of-care (POC) fingerstick blood sample rapid COVID-19 test kit. The Assure COVID-19 immunoglobulin G/ immunoglobulin M (IgG/IgM) Rapid Test kits received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) on September 23.

The kits are rapid chromatographic immunoassays that detect IgM and IgG antibodies to COVID-19 SARS-CoV-2 in blood. The kits can provide results in minutes.

The company is accepting orders for the kits from pharmacies, medical centers, and emergency responders throughout the U.S. 20/20 also plans to conduct studies to validate the use of an at-home fingerstick blood collection kit.

20/20 BioResponse is a business unit of 20/20 GeneSystems.

ProciseDx wins CE Mark for point-of-care tests
Nestlé Health Science subsidiary ProciseDx has received the European CE Mark for Procise IFX and Procise ADL, the company's infliximab and adalimumab...
Lab-on-a-chip array could provide low-cost SARS-CoV-2 antibody test
The University of California, Irvine has developed a low-cost lab-on-a-chip test called TinyArray that may be available for rapid COVID-19 diagnostic...
PerkinElmer debuts dried blood spot-based COVID-19 serology test
PerkinElmer has introduced a dry blood spot-based serology test for SARS-CoV-2 immunoglobulin G antibodies using its genetic screening processor/dissociation-enhanced...
ZRT launches dried blood antibody tests for SARS-CoV-2
ZRT Laboratory has introduced two new SARS-CoV-2 antibody detection products that use dried blood spot testing.
BioLab Sciences sells coronavirus finger-prick blood test in U.S.
Regenerative biotechnology firm BioLab Sciences has begun U.S. distribution of its test to detect antibodies specific to the novel coronavirus SARS-CoV-2.

Copyright © 2020 LabPulse.com

Last Updated ls 10/7/2020 3:45:09 PM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email